Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury.
(2024) Case Reports in Critical Care — Vol. 2024, p. 6631866 [1-5] (2024)
Files
2024_André_Case_Rep_Crit_Care.pdf
Open Access - Adobe PDF
- 573.21 KB
Details
- Authors
André, Elise 
Lemaitre, Florian Verdier, Marie-Clémence
- Abstract
- A 56-year-old woman was transferred to the intensive care unit (ICU) two days after an allogeneic stem cell transplantation (ASCT) when she presented acute respiratory distress due to the relapse of a SARS-CoV-2 infection. Following that, she received two intravenous doses of 100 mg remdesivir. Subsequently, the patient developed multiple instances of diarrhea, progressing to oliguria and acute kidney injury, necessitating continuous venovenous hemofiltration (CVVH). Despite the absence of signs of hypoxemia or cardiocirculatory failure requiring vasopressor intervention, a progressive lactic acidosis emerged. Two days after the onset of lactic acidosis, a significant rise in aminotransferases and lactate dehydrogenase occurred, in the absence of encephalopathy and coagulation disorders. Remdesivir therapy had been interrupted upon the initial signs of lactic acidosis. Despite an improvement in liver function tests and lactic acidosis, the patient's condition deteriorated, ultimately leading to her demise on day 29 due to newly arising hematological complications. Academic Editor: Mehmet Doganay
- Affiliations
Citations
André, E., Lemaitre, F., Verdier, M.-C., Haufroid, V., Pinto Pereira, J., & Hantson, P. (2024). Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury. Case Reports in Critical Care, 2024, 6631866 [1-5]. https://doi.org/10.1155/2024/6631866 (Original work published 2024)